期刊文献+

早期非小细胞肺癌射波刀放疗中肺部组织的剂量学分析 被引量:3

A dosimetric analysis of lung tissue in early stage non-small cell lung cancer patients treated by Cyberknife radiotherapy
原文传递
导出
摘要 目的 分析早期非小细胞肺癌患者采用射波刀治疗时,正常肺部组织所受剂量。方法 回顾性分析天津医科大学肿瘤医院射波刀中心2011年1月至2013年12月收治的264例早期非小细胞肺癌患者的放疗计划,根据肿瘤体积大小和位置不同,采用PTV区域剂量体积直方图(DVH)、剂量均匀指数(HI)、同侧和对侧肺组织接受照射的体积百分比V5、V10、V20和V30参数对物理计划进行评价,并对肿瘤贴近肺门患者的放疗计划,加入对侧肺组织保护进行优化,评价对侧肺和全肺组织的照射体积比。结果 贴近胸壁肿瘤的照射体积比:同侧肺组织V5≥(15.21±3.12)%,对侧肺组织V5≥(1.34±0.67)%。贴近肺门的肿瘤的照射体积比:同侧肺组织V5≥(39.4±11.90)%,对侧肺组织V5≥(1.48±0.34)%。同侧和对侧肺组织的照射体积比均随肿瘤体积增大而增大。加入对侧肺部保护限制进行重新优化设计后,对侧肺和全肺的照射体积比V5、V10有明显的降低(t=2.44、4.81、3.53、3.17,P<0.05)。结论 贴近肺门的肿瘤对同侧和对侧肺组织的放射性损伤明显高于贴近胸壁的肿瘤。加入对侧肺部保护进行优化放疗计划后,能够减小对侧肺和全肺组织的损伤,实现了保护正常肺部组织。 Objective To analyze the radiation dose to the normal lung tissue of patients with early stage of non-small cell lung cancer treated by Cyberknife.Methods A retrospective analysis was conducted by summarizing the treatment plans of 264 patients with early stage non-small cell lung cancer from January 2011 to December 2013 in Tianjin Medical University Cancer Institute and Hospital. Sorted by the tumor volumes and locations, the Cyberknife plans were evaluated by means of dose volume histograms (DVH), homogeneity indexes (HI), percentage volumes receiving at least x Gy (Vx) of dose, i.e., V5, V10, V20, and V30 of the ipsilateral and contralateral lungs. For the tumors approximate to the hilus, the contralateral lungs were included in the optimization process, and the dose-volume metrics were analyzed for the contralateral and bilateral lungs.Results For the tumors close to the chest wall, V5 ≥ (15.21±3.12)% in ipsilateral lung tissue and V5 ≥ (1.34±0.67)% in contralateral lung tissue were observed. For the tumors near the hilus, V5 ≥ (39.4±11.90)% in ipsilateral lung tissue and V5 ≥ (1.48±0.34)% in contralateral lung tissue were observed. The irradiated volume ratios of both ipsilateral and contralateral lung tissue increased with the enlargement of tumor sizes. After including the contralateral lung tissue into the optimization, the irradiated volume ratios of the contralateral and bilateral lung tissue (V5, V10) decreased significantly(t=2.44, 4.81, 3.53, 3.17, P<0.05).Conclusions Higher risk of radiation injury in both ipsilateral and contralateral lung tissue can be expected for tumors near the hilus than near the chest wall. After including contralateral lung tissue into the planning optimization, lower dose to the contralateral and whole lung tissue was achieved, indicating a better protection of normal lung tissue.
作者 王境生 于旭耀 李丰彤 董洋 陈华明 宋勇春 陶振 袁智勇 Wang Jingsheng;Yu Xuyao;Li Fengtong;Dong Yang;Chen Huaming;Song Yongchun;Tao Zhen;Yuan Zhiyong(Department of Radiotherapy,Tianfin Medical Urtiversity Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin Key Laboratory of Cancer Prevention and Therapy,Tianjin's Clinical Research Certter for Cancer)
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2018年第12期933-937,共5页 Chinese Journal of Radiological Medicine and Protection
关键词 射波刀 非小细胞肺癌 治疗计划 体积百分比 放射性肺炎 CyberKnife Non-small cell lung cancer Treatment plan Volume percentage Radiation pneumonitis
  • 相关文献

参考文献11

二级参考文献102

  • 1Hideomi Yamashita,Wataru Takahashi,Akihiro Haga,Keiichi Nakagawa.Radiation pneumonitis after stereotactic radiation therapy for lung cancer[J].World Journal of Radiology,2014,6(9):708-715. 被引量:22
  • 2杨瑞杰,戴建荣,张红志.肺癌放疗中的呼吸运动问题及解决方法[J].中华放射肿瘤学杂志,2005,14(5):461-463. 被引量:13
  • 3许峰,柏森,张洪,钟仁明,蒋小芹,沈亚丽,徐庆丰,李小玉.肺癌图像引导下大分割放射治疗技术初探[J].中国肺癌杂志,2006,9(4):345-348. 被引量:4
  • 4Scott WJ,Howington J,Feigenberg S,et al.Treatment of nonsmall cell lung cancer stage Ⅰ and stage Ⅱ:ACCP evidence-based clinical practice guidelines(2nd edition).Chest,2007,132(3 Suppl):234-242.
  • 5Raz DJ,Zell JA,Ignatius OS,et al.Natural history of stage Ⅰ non-small cell lung cancer:implications for early detection.Chest,2007,132:193-199.
  • 6Patrick T,Susan GA,Elizabeth A.New guidelines to evaluate the response to treatment in solid tumors.J Natl Cancer Inst,2000,92:205-215.
  • 7National Cancer Institute.Cancer therapy evaluation program,common terminology criteria for adverse events.version 3.0.Washington:NCI,2003.
  • 8Ginberg RJ,Rubinstein LV.Lung Cancer Study Group(1995)Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer.Ann Thorac Surg,1995,60:615-623.
  • 9Mountain CF.A new international staging system for lung cancer.Chest,1986,89:225-233.
  • 10Timmerman R,Papiez L,McGarry R,et al.Extracranial stereotacti cradioablation:results of a phase Ⅰ study in medically inoperable stage Ⅰ non-small cell lung cancer.Chest,2003;124:1946-1955.

共引文献155

同被引文献22

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部